Loading clinical trials...
Loading clinical trials...
A Phase 1, Randomized, Subject- and Investigator-Blind, Placebo-Controlled, Parallel-Group, Single and Multiple-Dose Study of Desvenlafaxine in Korean Healthy Subjects
Conditions
Interventions
desvenlafaxine
desvenlafaxine
+1 more
Locations
1
South Korea
Pfizer Investigational Site
Seoul, South Korea
Start Date
November 1, 2011
Primary Completion Date
December 1, 2011
Completion Date
December 1, 2011
Last Updated
January 2, 2012
NCT07115329
NCT06793397
NCT07025720
NCT06780917
NCT04480918
NCT07329621
Lead Sponsor
Pfizer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions